The 2026 BioInnovate Conference brings together academic founders with investors, industry representatives, entrepreneurs and ecosystem partners with the expressed goal of finding opportunities to connect and collaborate. The conference is a rare opportunity to meet a diverse group of life science inventors and spinout companies across therapeutics, device, digital health and diagnostic sectors. All Weill Cornell Medicine-affiliated inventors are encouraged to participate.

Over the years, this event has been a proven catalyst for direct investment from early-stage investors, co-development relationships with industry, and introductions to experienced management teams.